中国医药导报
中国医药期刊欢迎您 今天是   2025年4月15日星期二
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报  2023, Vol. 20 Issue (29): 152-156    DOI: 10.20047/j.issn1673-7210.2023.29.33
  中医中药 本期目录 | 过刊浏览 | 高级检索 |
“体阴用阳治脑病”理论下益髓复用汤治疗痴呆的效果
唐国华  朱建伟  陶文强
成都中医药大学第四临床医学院,重庆 402682
Effect of Yisui Fuyong Decoction on dementia under the theory of “treating encephalopathy with yin constitution based on warming yang method”
TANG Guohua ZHU Jianwei TAO Wenqiang
The Fourth Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chongqing 402682, China
全文: PDF (698 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨“体阴用阳治脑病”理论下益髓复用汤治疗痴呆的效果。 方法 选取2020年7月至2022年7月收治于成都中医药大学第四临床医学院的老年期痴呆患者78例,根据随机数字表法将其分为治疗组和对照组,每组39例。对照组给予盐酸多奈哌齐片,治疗组在对照组基础上加用益髓复用汤,两组均治疗6个月。比较两组治疗前后简易精神状态检查量表(MMSE)、Barthel指数、血清同型半胱氨酸(Hcy)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)、中医症状积分和治疗后临床效果。 结果 治疗后,两组MMSE、Barthel指数评分均较治疗前升高,且治疗组高于对照组,差异有统计学意义(P<0.05)。治疗后,两组Hcy、TNF-α和IL-6水平较治疗前降低,且治疗组TNF-α和IL-6水平低于对照组,差异有统计学意义(P<0.05);两组Hcy水平比较,差异无统计学意义(P>0.05)。治疗后,两组中医症状积分较治疗前降低,且治疗组低于对照组,差异有统计学意义(P<0.05)。治疗组治疗效果优于对照组,差异有统计学意义(P<0.05)。 结论 “体阴用阳治脑病”理论下益髓复用汤治疗痴呆可提高效果,改善患者临床症状,值得临床推广应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
唐国华  朱建伟  陶文强
关键词 痴呆体阴用阳益髓复用汤盐酸多奈哌齐    
Abstract:Objective To investigate the effect of Yisui Fuyong Decoction on dementia under the theory of “treating encephalopathy with yin constitution based on warming yang method”. Methods A total of 78 patients with senile dementia admitted to The Fourth Clinical Medical College, Chengdu University of Traditional Chinese Medicine from July 2020 to July 2022 were selected and they were divided into treatment group and control group according to random number table method, with 39 cases in each group. The control group was given Donepezil Hydrochloride Tablets, and the treatment group was given Yisui Fuyong Decoction on the basis of the control group. Both groups were treated for six months. The mini mental status examination (MMSE), Barthel index, serum homocysteine (Hcy), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), traditional Chinese medicine symptom score were compared between the two groups before and after treatment and clinical effect was compared after treatment. Results After treatment, MMSE and Barthel index scores in both groups were higher than before treatment, and those in the treatment group were higher than those in the control group, the differences were statistically significant (P<0.05). After treatment, the levels of Hcy, TNF-α, and IL-6 in two groups were lower than before treatment, and the levels of TNF-α and IL-6 in treatment group were lower than those in control group, the differences were statistically significant (P<0.05). There was no significant difference in Hcy level between the two groups (P>0.05). After treatment, the traditional Chinese medicine symptom score of the two groups was lower than that before treatment, and that of the treatment group was lower than that of the control group, the differences were statistically significant (P<0.05). The therapeutic effect of the treatment group was better than that of the control group, and the difference was statistically significant (P<0.05). Conclusion Under the theory of “treating encephalopathy with yin constitution based on warming yang method”, Yisui Fuyong Decoction can improve the effect of dementia and improve the clinical symptoms of patients, which is worthy of clinical application.
Key wordsDementia    Yin constitution based on warming yang method    Yisui Fuyong Decoction    Donepezil Hydrochloride
    
基金资助:重庆市自然科学基金面上项目(cstc2020jcyj- msxmX0011);
重庆市科卫联合中医药科研项目(2020ZY 023533、2021ZY023596)。
通讯作者: 陶文强(1984.2-),男,博士,副主任中医师;研究方向:中西医结合治疗脑病急症。   
作者简介: 唐国华(1990.12-),男,硕士;研究方向:中医药防治脑血管病。
引用本文:   
唐国华  朱建伟  陶文强. “体阴用阳治脑病”理论下益髓复用汤治疗痴呆的效果[J]. 中国医药导报, 2023, 20(29): 152-156.
TANG Guohua ZHU Jianwei TAO Wenqiang. Effect of Yisui Fuyong Decoction on dementia under the theory of “treating encephalopathy with yin constitution based on warming yang method”. 中国医药导报, 2023, 20(29): 152-156.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.29.33     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I29/152

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司